Suchergebnisse - "Hsu, Ping-Chih"

PubPharm (80)

1

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study

enthalten in: ResearchSquare.com | 2024

von Chiu, L. | Lee, C. | Hsu, P. | +10

2

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19 : a bicenter observational cohort study

enthalten in: Environmental health : a global access science source | 2024

von Chiu, L. | Lee, C. | Hsu, P. | +10

3

Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study

enthalten in: Environmental health | 2024

von Chiu, L. | Lee, C. | Hsu, P. | +10

4

Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer

enthalten in: Thoracic cancer | 2024

von Chiu, L. | Hsu, P. | Wang, C. | +6

5

A Real-World Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive Stage Small Cell Lung Cancer

enthalten in: ResearchSquare.com | 2024

von Hsu, P. | Wu, B. | Wang, C. | +10

6

Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer : a multi-institute retrospective study

enthalten in: Aging | 2024

von Hung, L. | Hsu, P. | Yang, C. | +5

7

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

enthalten in: Therapeutic advances in medical oncology | 2024

von Tung, P. | Chiu, T. | Huang, A. | +10

8

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

enthalten in: Scientific reports | 2023

von Ju, J. | Huang, A. | Tung, P. | +10

9

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib

enthalten in: Thoracic cancer | 2023

von Wu, C. | Hsu, P. | Chang, J. | +6

10

Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I) : A Multicenter Observational Study in Taiwan

enthalten in: Targeted oncology | 2023

von Hsu, P. | Lee, S. | Chiu, L. | +9

1
2
3
4
5
6
7
8
Nächster »
[8]